BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sedghi S, Fields JZ, Klamut M, Urban G, Durkin M, Winship D, Fretland D, Olyaee M, Keshavarzian A. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut. 1993;34:1191-1197. [PMID: 8406152 DOI: 10.1136/gut.34.9.1191] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Chami B, Martin NJ, Dennis JM, Witting PK. Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease. Archives of Biochemistry and Biophysics 2018;645:61-71. [DOI: 10.1016/j.abb.2018.03.012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 22.7] [Reference Citation Analysis]
2 Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, Lee KR, Kim WH. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci. 2009;54:1525-1531. [PMID: 18975078 DOI: 10.1007/s10620-008-0514-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
3 Ramakrishna BS, Varghese R, Jayakumar S, Mathan M, Balasubramanian KA. Circulating antioxidants in ulcerative colitis and their relationship to disease severity and activity. J Gastroenterol Hepatol. 1997;12:490-494. [PMID: 9257238 DOI: 10.1111/j.1440-1746.1997.tb00471.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
4 Ito M, Ohishi K, Yoshida Y, Okumura T, Sato T, Yokoi W, Sawada H. Preventive effect of Streptococcus thermophilus YIT 2001 on dextran sulfate sodium-induced colitis in mice. Biosci Biotechnol Biochem 2008;72:2543-7. [PMID: 18838819 DOI: 10.1271/bbb.80240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
5 Baek IJ, Seo DS, Yon JM, Lee SR, Jin Y, Nahm SS, Jeong JH, Choo YK, Kang JK, Lee BJ, Yun YW, Nam SY. Tissue expression and cellular localization of phospholipid hydroperoxide glutathione peroxidase (PHGPx) mRNA in male mice. J Mol Histol 2007;38:237-44. [PMID: 17503194 DOI: 10.1007/s10735-007-9092-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
6 Zhang D, Wei Y, Chen K, Zhang X, Xu X, Shi Q, Han S, Chen X, Gong H, Li X, Zhang J. Biocompatible Reactive Oxygen Species (ROS)-Responsive Nanoparticles as Superior Drug Delivery Vehicles. Adv Healthcare Mater 2015;4:69-76. [DOI: 10.1002/adhm.201400299] [Cited by in Crossref: 82] [Cited by in F6Publishing: 68] [Article Influence: 11.7] [Reference Citation Analysis]
7 Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58:87-114. [PMID: 16507884 DOI: 10.1124/pr.58.1.6] [Cited by in Crossref: 706] [Cited by in F6Publishing: 541] [Article Influence: 47.1] [Reference Citation Analysis]
8 Nunes R, Neves JD, Sarmento B. Nanoparticles for the regulation of intestinal inflammation: opportunities and challenges. Nanomedicine (Lond) 2019;14:2631-44. [PMID: 31612773 DOI: 10.2217/nnm-2019-0191] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
9 Zhou Y, Wang Q, Evers BM, Chung DH. Signal transduction pathways involved in oxidative stress-induced intestinal epithelial cell apoptosis. Pediatr Res. 2005;58:1192-1197. [PMID: 16306192 DOI: 10.1203/01.pdr.0000185133.65966.4e] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
10 Robinson CE, Kottapalli V, D'astice M, Fields JZ, Winship D, Keshavarzian A. Regulation of neutrophils in ulcerative colitis by colonic factors: A possible mechanism of neutrophil activation and tissue damage. Journal of Laboratory and Clinical Medicine 1997;130:590-602. [DOI: 10.1016/s0022-2143(97)90109-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater. 2010;9:923-928. [PMID: 20935658 DOI: 10.1038/nmat2859] [Cited by in Crossref: 416] [Cited by in F6Publishing: 356] [Article Influence: 37.8] [Reference Citation Analysis]
12 Bronsart L, Nguyen L, Habtezion A, Contag C. Reactive Oxygen Species Imaging in a Mouse Model of Inflammatory Bowel Disease. Mol Imaging Biol 2016;18:473-8. [PMID: 26873653 DOI: 10.1007/s11307-016-0934-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 5.8] [Reference Citation Analysis]
13 Li X, Lu C, Yang Y, Yu C, Rao Y. Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease. Biomed Pharmacother 2020;129:110486. [PMID: 32768972 DOI: 10.1016/j.biopha.2020.110486] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
14 Kruidenier L, Verspaget HW. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol Ther. 2002;16:1997-2015. [PMID: 12452933 DOI: 10.1046/j.1365-2036.2002.01378.x] [Cited by in Crossref: 251] [Cited by in F6Publishing: 226] [Article Influence: 13.9] [Reference Citation Analysis]
15 Rochat T, Bermúdez-Humarán L, Gratadoux JJ, Fourage C, Hoebler C, Corthier G, Langella P. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb Cell Fact. 2007;6:22. [PMID: 17659075 DOI: 10.1186/1475-2859-6-22] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 5.9] [Reference Citation Analysis]
16 Olyaee M, Sontag S, Salman W, Schnell T, Mobarhan S, Eiznhamer D, Keshavarzian A. Mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. Gut. 1995;37:168-173. [PMID: 7557561 DOI: 10.1136/gut.37.2.168] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 2.8] [Reference Citation Analysis]
17 Blackburn AC, Doe WF, Buffinton GD. Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. Free Radical Biology and Medicine 1999;27:262-70. [DOI: 10.1016/s0891-5849(99)00065-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
18 Farhadi A, Keshavarzian A, Fitzpatrick LR, Mutlu E, Zhang Y, Banan A. Modulatory effects of plasma and colonic milieu of patients with ulcerative colitis on neutrophil reactive oxygen species production in presence of a novel antioxidant, rebamipide. Dig Dis Sci 2002;47:1342-8. [PMID: 12064811 DOI: 10.1023/a:1015382800434] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
19 Pritchard RE, Balish MF. Mycoplasma iowae: relationships among oxygen, virulence, and protection from oxidative stress. Vet Res 2015;46:36. [PMID: 25880161 DOI: 10.1186/s13567-015-0170-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
20 Gaginella TS, Kachur JF, Tamai H, Keshavarzian A. Reactive oxygen and nitrogen metabolites as mediators of secretory diarrhea. Gastroenterology. 1995;109:2019-2028. [PMID: 7498670 DOI: 10.1016/0016-5085(95)90772-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 1.6] [Reference Citation Analysis]
21 Haydek JM, Keshavarzian A. Circulating neutrophils from patients with ulcerative colitis have a normal respiratory burst. Inflammation 1995;19:701-15. [PMID: 8595936 DOI: 10.1007/BF01534573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Dou Y, Li C, Li L, Guo J, Zhang J. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327:641-66. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
23 Choudhary S, Keshavarzian A, Yong S, Wade M, Bocckino S, Day BJ, Banan A. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci 2001;46:2222-30. [PMID: 11680601 DOI: 10.1023/a:1011975218006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
24 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
25 Tanida S, Mizoshita T, Mizushima T, Sasaki M, Shimura T, Kamiya T, Kataoka H, Joh T. Involvement of oxidative stress and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in inflammatory bowel disease. J Clin Biochem Nutr. 2011;48:112-116. [PMID: 21373262 DOI: 10.3164/jcbn.10-41] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
26 Barbosa DS, Cecchini R, El Kadri MZ, Rodríguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition. 2003;19:837-842. [PMID: 14559317 DOI: 10.1016/s0899-9007(03)00162-x] [Cited by in Crossref: 126] [Cited by in F6Publishing: 36] [Article Influence: 7.4] [Reference Citation Analysis]
27 Ko JK, Lam FY, Cheung AP. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol. 2005;11:5787-5794. [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
28 Schreiber S, Keshavarzian A, Isaacs KL, Schollenberger J, Guzman JP, Orlandi C, Hanauer SB. A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology. 2007;132:76-86. [PMID: 17241861 DOI: 10.1053/j.gastro.2006.11.029] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
29 Narushima S, Spitz DR, Oberley LW, Toyokuni S, Miyata T, Gunnett CA, Buettner GR, Zhang J, Ismail H, Lynch RG. Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice. Free Radic Biol Med. 2003;34:1153-1166. [PMID: 12706496 DOI: 10.1016/S0891-5849(03)00065-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
30 Keshavarzian A, Fields JZ. A radical perspective on ulcerative colitis. J Gastroenterol Hepatol 1995;10:208-9. [DOI: 10.1111/j.1440-1746.1995.tb01080.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
31 Ardite E, Sans M, Panés J, Romero FJ, Piqué JM, Fernández-Checa JC. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab Invest. 2000;80:735-744. [PMID: 10830784 DOI: 10.1038/labinvest.3780077] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 3.7] [Reference Citation Analysis]
32 Farhadi A, Banan A, Fields J, Keshavarzian A. Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol. 2003;18:479-497. [PMID: 12702039 DOI: 10.1046/j.1440-1746.2003.03032.x] [Cited by in Crossref: 287] [Cited by in F6Publishing: 245] [Article Influence: 15.9] [Reference Citation Analysis]
33 Oldenburg B, van Kats-Renaud H, Koningsberger JC, van Berge Henegouwen GP, van Asbeck BS. Chemiluminescence in inflammatory bowel disease patients: a parameter of inflammatory activity. Clin Chim Acta. 2001;310:151-156. [PMID: 11498080 DOI: 10.1016/s0009-8981(01)00569-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Cicalese L, Caraceni P, Nalesnik MA, Borle AB, Schraut WH. Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation. 1996;62:161-166. [PMID: 8755810 DOI: 10.1097/00007890-199607270-00003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
35 Zhou Y, Cho KJ, Plowman SJ, Hancock JF. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of Ras proteins on the plasma membrane. J Biol Chem 2012;287:16586-95. [PMID: 22433858 DOI: 10.1074/jbc.M112.348490] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
36 Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, Chen Z. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. Int J Pharm 2021;600:120461. [PMID: 33711470 DOI: 10.1016/j.ijpharm.2021.120461] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 D'Odorico A, D'Inca R, Mestriner C, Di Leo V, Ferronato A, Sturniolo GC. Influence of disease site and activity on peripheral neutrophil function in inflammatory bowel disease. Dig Dis Sci. 2000;45:1594-1600. [PMID: 11007111 DOI: 10.1023/a:1005521212948] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhao C, Huang H, Pan Q, Huang W, Peng W, Xu H, Feng Z, Du Y, Nie Y, Zhou Y. Unconjugated Bilirubin Attenuates DSS-Induced Colitis Potentially via Enhancement of Bilirubin Reabsorption. Front Pharmacol 2021;12:654808. [PMID: 34093187 DOI: 10.3389/fphar.2021.654808] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol. 1999;94:704-712. [PMID: 10086655 DOI: 10.1111/j.1572-0241.1999.00940.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 3.1] [Reference Citation Analysis]
40 del Carmen S, de Moreno de Leblanc A, Miyoshi A, Santos Rocha C, Azevedo V, Leblanc JG. Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases. Ulcers 2011;2011:1-13. [DOI: 10.1155/2011/841651] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
41 Keshavarzian A, Haydek JM, Jacyno M, Holmes EW, Harford F. Modulatory effects of the colonic milieu on neutrophil oxidative burst: A possible pathogenic mechanism of ulcerative colitis. Journal of Laboratory and Clinical Medicine 1997;130:216-25. [DOI: 10.1016/s0022-2143(97)90099-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
42 Zhou Y, Wang Q, Mark Evers B, Chung DH. Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK. Biochem Biophys Res Commun 2006;350:860-5. [PMID: 17034759 DOI: 10.1016/j.bbrc.2006.09.103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
43 Sangfelt P, Carlson M, Thörn M, Lööf L, Raab Y. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol. 2001;96:1085-1090. [PMID: 11316151 DOI: 10.1111/j.1572-0241.2001.03743.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
44 Oshitani N, Campbell A, Bloom S, Kitano A, Kobayashi K, Jewell DP. Adhesion Molecule Expression on Vascular Endothelium and Nitroblue Tetrazolium Reducing Activity in Human Colonic Mucosa. Scandinavian Journal of Gastroenterology 2009;30:915-20. [DOI: 10.3109/00365529509101601] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
45 Salh BS, Martens J, Hundal RS, Yoganathan N, Charest D, Mui A, Gómez-muñoz A. PD98059 Attenuates Hydrogen Peroxide-Induced Cell Death through Inhibition of Jun N-Terminal Kinase in HT29 Cells. Molecular Cell Biology Research Communications 2000;4:158-65. [DOI: 10.1006/mcbr.2001.0271] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
46 Scigliano G, Girotti F, Soliveri P, Musicco M, Radice D, Caraceni T. Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis? Ital J Neuro Sci 1997;18:69-72. [DOI: 10.1007/bf01999565] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
47 González R, Rodríguez S, Romay, C, González A, Armesto, J, Remirez D, Merino N. ANTI-INFLAMMATORY ACTIVITY OF PHYCOCYANIN EXTRACT IN ACETIC ACID-INDUCED COLITIS IN RATS. Pharmacological Research 1999;39:55-9. [DOI: 10.1006/phrs.1998.0409] [Cited by in Crossref: 127] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
48 Li S, Xie A, Li H, Zou X, Zhang Q. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease. J Control Release 2019;316:66-78. [PMID: 31682913 DOI: 10.1016/j.jconrel.2019.10.054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
49 Li CW, Li LL, Chen S, Zhang JX, Lu WL. Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases. Front Bioeng Biotechnol 2020;8:200. [PMID: 32258013 DOI: 10.3389/fbioe.2020.00200] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 15.0] [Reference Citation Analysis]
50 Yu H, Sato EF, Nagata K, Nishikawa M, Kashiba M, Arakawa T, Kobayashi K, Tamura T, Inoue M. Oxygen-dependent regulation of the respiration and growth of Escherichia coli by nitric oxide. FEBS Lett 1997;409:161-5. [PMID: 9202138 DOI: 10.1016/s0014-5793(97)00494-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
51 Gao F, Horie T. A synthetic analog of prostaglandin E1 prevents the production of reactive oxygen species in the intestinal mucosa of methotrexate-treated rats. Life Sciences 2002;71:1091-9. [DOI: 10.1016/s0024-3205(02)01795-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
52 Asghar MN, Emani R, Alam C, Helenius TO, Grönroos TJ, Sareila O, Din MU, Holmdahl R, Hänninen A, Toivola DM. In vivo imaging of reactive oxygen and nitrogen species in murine colitis. Inflamm Bowel Dis 2014;20:1435-47. [PMID: 24983980 DOI: 10.1097/MIB.0000000000000118] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
53 Zhang Q, Tao H, Lin Y, Hu Y, An H, Zhang D, Feng S, Hu H, Wang R, Li X, Zhang J. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease. Biomaterials 2016;105:206-21. [DOI: 10.1016/j.biomaterials.2016.08.010] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 17.6] [Reference Citation Analysis]
54 Jung YS, Park JJ, Kim SW, Hong SP, Kim TI, Kim WH, Cheon JH. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases. Dig Liver Dis 2012;44:897-903. [PMID: 22721842 DOI: 10.1016/j.dld.2012.05.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
55 Calle D, Ballesteros P, Cerdán S. Advanced Contrast Agents for Multimodal Biomedical Imaging Based on Nanotechnology. Methods Mol Biol 2018;1718:441-57. [PMID: 29341024 DOI: 10.1007/978-1-4939-7531-0_26] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
56 Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett’s esophagus, and the latter’s progression toward esophageal cancer? Am J Gastroenterol. 2002;97:22-26. [PMID: 11808965 DOI: 10.1111/j.1572-0241.2002.05444.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 3.7] [Reference Citation Analysis]
57 Chen F, Liu Q, Xiong Y, Xu L. Current Strategies and Potential Prospects of Nanomedicine-Mediated Therapy in Inflammatory Bowel Disease. Int J Nanomedicine 2021;16:4225-37. [PMID: 34188471 DOI: 10.2147/IJN.S310952] [Reference Citation Analysis]
58 Uchiyama K, Naito Y, Takagi T, Mizushima K, Hirai Y, Hayashi N, Harusato A, Inoue K, Fukumoto K, Yamada S, Handa O, Ishikawa T, Yagi N, Kokura S, Yoshikawa T. Serpin B1 protects colonic epithelial cell via blockage of neutrophil elastase activity and its expression is enhanced in patients with ulcerative colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2012;302:G1163-70. [DOI: 10.1152/ajpgi.00292.2011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
59 Date AA, Hanes J, Ensign LM. Nanoparticles for oral delivery: Design, evaluation and state-of-the-art. J Control Release 2016;240:504-26. [PMID: 27292178 DOI: 10.1016/j.jconrel.2016.06.016] [Cited by in Crossref: 184] [Cited by in F6Publishing: 126] [Article Influence: 36.8] [Reference Citation Analysis]
60 Wéra O, Lancellotti P, Oury C. The Dual Role of Neutrophils in Inflammatory Bowel Diseases. J Clin Med 2016;5:E118. [PMID: 27999328 DOI: 10.3390/jcm5120118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 79] [Article Influence: 20.2] [Reference Citation Analysis]
61 Regmi S, Pathak S, Nepal MR, Shrestha P, Park J, Kim JO, Yong CS, Choi D, Chang J, Jeong TC, Orive G, Yook S, Jeong J. Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation. Journal of Controlled Release 2019;316:138-49. [DOI: 10.1016/j.jconrel.2019.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
62 Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, Panetta J, Morris CJ, Blake DR. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 1996;39:407-415. [PMID: 8949646 DOI: 10.1136/gut.39.3.407] [Cited by in Crossref: 176] [Cited by in F6Publishing: 157] [Article Influence: 7.3] [Reference Citation Analysis]
63 Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci. 1998;43:1088-1095. [PMID: 9590426 DOI: 10.1023/a:1018899222258] [Cited by in Crossref: 55] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
64 Loguercio C, D'argenio G, Cave MD, Cosenza V, Valle ND, Mazzacca G, Blanco CDV. Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Digest Dis Sci 1996;41:1204-11. [DOI: 10.1007/bf02088238] [Cited by in Crossref: 55] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]